RDInvesting Provides Investors with Free In-Depth Equity Reports on MUR, OPTR, PBI and WEN
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Murphy Oil Corporation (NYSE: MUR) shares declined 1.23 percent to close at $67.71 a share Wednesday. The stock traded between $67.21 and $68.65 on volume of 1.35 million shares traded. Analysts at RBC Capital have recently upgraded the company’s rating to “sector perform” from “outperform”. Shares of Murphy Oil have gained approximately 59.0 percent year-to-date.
Find out more about Murphy Oil including full access to the free equity report at:
www.RDInvesting.com/MUR
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) declined 1.38 percent to close at $13.55 a share Wednesday. The stock traded between $13.28 and $13.94 on volume of 949,142 shares traded. Analysts at Zacks have recently upgraded the company’s rating to “neutral” from “underperform”. Shares of Optimer Pharmaceuticals have gained approximately 50.0 percent year-to-date.
Find out more about Optimer Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/OPTR
Pitney Bowes Inc. (NYSE: PBI) closed at $15.54 a share Wednesday. The stock traded between $14.43 and $14.69 on volume of 5.81 million shares traded. Analysts at Piper Jaffray have recently initiated coverage on the company with a “neutral” rating and a price target of $16.00. Shares of Pitney Bowes have gained approximately 36.5 percent year-to-date.
Find out more about Pitney Bowes including full access to the free equity report at:
www.RDInvesting.com/PBI
The Wendy's Co. (NASDAQ: WEN) shares declined 1.52 percent to close at $7.12 a share Wednesday. The stock traded between $7.04 and $7.34 on volume of 11.39 million shares traded. Analysts at Goldman Sachs have recently upgraded the company’s rating to “neutral” from “sell”. Shares of Wendy's have gained approximately 30.0 percent year-to-date.
Find out more about Wendy's including full access to the free equity report at:
www.RDInvesting.com/WEN
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com